{"product_id":"scripps-15th-annual-structural-heart-intervention-and-imaging-2026","title":"Scripps 15th Annual Structural Heart Intervention and Imaging 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: interventional cardiologists, echocardiographers, and cardiac surgeons\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eBuild and optimize a multidisciplinary team of health care professionals to ensure appropriate management of patients with structural heart disease.\u003c\/p\u003e\n\u003cp\u003eIdentify the equipment and imaging technologies necessary to perform structural heart disease interventions.\u003c\/p\u003e\n\u003cp\u003eApply a comprehensive approach to the assessment of the aortic, mitral, and tricuspid valves, the interatrial septum, and the left and right ventricles, using echocardiography (TTE, TEE, and ICE), CT, and MRI for the purpose of the interventional treatment of these cardiac structures.\u003c\/p\u003e\n\u003cp\u003eOutline the current indications for LAA closure, PFO closure, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), and mitral transcatheter edge to edge repair (TEER).\u003c\/p\u003e\n\u003cp\u003eEvaluate echocardiographic and CT imaging before and after LAA closure, and identify and measure peri-device leaks, device-related thrombus, and other potential complications.\u003c\/p\u003e\n\u003cp\u003eIdentify appropriate treatment strategies for patients with mitral valve disease (i.e., TEER or TMVR) or tricuspid valve disease (i.e., TEER or TTVR) based upon imaging findings.\u003c\/p\u003e\n\u003cp\u003eIncorporate live TEE multiplanar imaging to optimize transcatheter mitral and tricuspid valve intervention.\u003c\/p\u003e\n\u003cp\u003eApply 2D and 4D ICE during structural heart intervention.\u003c\/p\u003e\n\u003cp\u003eRecognize the risk of left ventricular outflow tract obstruction after TMVR and coronary occlusion after TAVR and apply specific interventional strategies to prevent them (e.g., LAMPOON and BASILICA).\u003c\/p\u003e\n\u003cp\u003eIntegrate emerging data regarding surgical risk, including low and intermediate-risk patients into TAVR decision-making.\u003c\/p\u003e\n\u003cp\u003eRecognize heart failure patients who might benefit from novel interventional strategies, such as interatrial shunt devices, to improve symptoms.\u003c\/p\u003e\n\u003cp\u003eOptimize the anesthetic management of patients with reduced ejection fraction undergoing TEER or TMVR.\u003c\/p\u003e\n\u003cp\u003eEmploy best practices to safely manage potential complications of catheter-based therapies for structural heart disease.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for interventional cardiologists, echocardiographers, and cardiac surgeons who want advanced training in structural heart interventions and imaging.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 San Diego Transcatheter Edge-to-Edge Repair Conclave\u003c\/p\u003e\n\u003cp\u003e02 Best Practices for T-TEER Procedural Strategy\u003c\/p\u003e\n\u003cp\u003e03 Getting off the Struggle Bus During TEE Imaging How to Acquire the Key Views When Imaging is Challenging\u003c\/p\u003e\n\u003cp\u003e05 Invited T-TEER Case Presentation from San Diego Operator Imaging Team, with Panel Discussion Arvin Narula, MD\u003c\/p\u003e\n\u003cp\u003e06 Invited T-TEER Case Presentation from San Diego Operator Imaging Team, with Panel Discussion Ryan Reeves, MD\u003c\/p\u003e\n\u003cp\u003e07 New Frontiers in MR and TR Treatment PASCAL Precision System Predictability and the Era of EVOQUE TTVR Amr Mohsen, MD\u003c\/p\u003e\n\u003cp\u003e08 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e09 Clinical-Pathological Correlations The Left Atrial Appendage\u003c\/p\u003e\n\u003cp\u003e10 TEE vs. 3D ICE for LAAO Procedural Guidance Strengths, Weaknesses, and How to Choose\u003c\/p\u003e\n\u003cp\u003e11 Interpreting CT Imaging After LAAO Leaks, HALT, DRT, and Device Position\u003c\/p\u003e\n\u003cp\u003e12 LAAO Is Safe Until It’s Not Untoward Events During and After the Procedure and How to Prevent Them\u003c\/p\u003e\n\u003cp\u003e13 Managing Peri-Device Leak Who to Treat and Technically How to Do It VIDEO PDF NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e14 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e15 Clinical-Pathological Correlations The Right Ventricle\u003c\/p\u003e\n\u003cp\u003e16 Current State-of-the-Art to Assess Right Ventricular Function by TTE, CT, and MRI\u003c\/p\u003e\n\u003cp\u003e17 Managing RV Function Before and After Tricuspid Intervention\u003c\/p\u003e\n\u003cp\u003e18 Atrial Functional MR Identification, Mechanism of Action, and Potential Treatments\u003c\/p\u003e\n\u003cp\u003e19 Lead-ing into Trouble How to Identify Lead-tricuspid Leaflet Interaction\u003c\/p\u003e\n\u003cp\u003e20 CHAMPIONing Watchman FLX as a Front-line Treatment OPTION for AF Stroke Prevention\u003c\/p\u003e\n\u003cp\u003e21 What’s the Optimal Post-Procedure Medication Regiment after Watchman FLX PRO\u003c\/p\u003e\n\u003cp\u003e22 Addressing Unmet Needs in LAAC with Watchman Next Generation (NG)\u003c\/p\u003e\n\u003cp\u003e23 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e24 Clinical-Pathological Correlations The Mitral Valve\u003c\/p\u003e\n\u003cp\u003e25 Cutting Edge Assessment of Mitral Regurgitation in 2026 Quantification, Mechanism, and Localization of Pathology\u003c\/p\u003e\n\u003cp\u003e26 Mitral TEER for Moderate MR Current Data and Future Directions\u003c\/p\u003e\n\u003cp\u003e27 Deep Dive and Clinical Implications of the ENCIRCLE Trial Patient Selection and Technique for Balloon-Expandable-in-Dock TMVR\u003c\/p\u003e\n\u003cp\u003e28 Advanced Techniques to Prevent LVOTO After Mitral Valve-in-Valve Implantation\u003c\/p\u003e\n\u003cp\u003e29 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e30 Concomitant LAA Closure and Mitral TEER Current Evidence and Procedural Considerations\u003c\/p\u003e\n\u003cp\u003e31 Interatrial Shunts for HFpEF and HFrEF Device and Data Update\u003c\/p\u003e\n\u003cp\u003e32 Imaging for Transseptal Puncture to Optimize Safety and Procedural Success\u003c\/p\u003e\n\u003cp\u003e33 Aortic Insufficiency Imaging Evaluation and Indications for Intervention\u003c\/p\u003e\n\u003cp\u003e34 Dedicated TAVI for Aortic Insufficiency Has Arrived Patient Selection, Technology, and Procedural Technique\u003c\/p\u003e\n\u003cp\u003e35 Contemporary Outcomes Data with Amulet and the Next Big Randomized Trial A CATALYST for Change\u003c\/p\u003e\n\u003cp\u003e37 Optimizing Procedural Outcomes and Safety Case Examples of Amulet LAAO\u003c\/p\u003e\n\u003cp\u003e38 Current State-of-the-art and Unmet Clinical Needs for the Treatment of Aortic Regurgitation\u003c\/p\u003e\n\u003cp\u003e39 Imaging for Aortic Regurgitation From Diagnosis to Patient Selection\u003c\/p\u003e\n\u003cp\u003e40 Transcatheter Intervention for Aortic Regurgitation Emerging Technologies, Clinical Trial Data, and Case Examples\u003c\/p\u003e\n\u003cp\u003e41 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e42 Clinical-Pathological Correlations The Tricuspid Valve\u003c\/p\u003e\n\u003cp\u003e43 Cutting Edge Assessment of the Tricuspid Valve by Echo Imaging Part I TR Quantification and Mechanisms of Action\u003c\/p\u003e\n\u003cp\u003e44 Tricuspid Surgery for TR Technique, Outcomes, and Lessons Learned for the Transcatheter Experience\u003c\/p\u003e\n\u003cp\u003e45 Cutting Edge Assessment of the Tricuspid Valve by Echo Imaging Part II Screening for T-TEER and TTVR\u003c\/p\u003e\n\u003cp\u003e46 Cerebral Protection for TAVR in 2026 How to Apply the Latest Data to Your Practice\u003c\/p\u003e\n\u003cp\u003e47 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e48 Optimizing T-TEER Outcomes How to Identify the Right (and Wrong) Patient\u003c\/p\u003e\n\u003cp\u003e49 Insertion, Insertion, Insertion Imaging Strategies to Confirm Leaflet Grasping During T-TEER\u003c\/p\u003e\n\u003cp\u003e50 Optimizing TTVR Outcomes How to Identify the Right (and Wrong) Patient\u003c\/p\u003e\n\u003cp\u003e51 Hands Off the Valve! The Role of Caval Valve Implantation (CAVI) in Severe TR\u003c\/p\u003e\n\u003cp\u003e52 Keys to Enhance Procedural Safety During TTVR\u003c\/p\u003e\n\u003cp\u003e53 The Value Proposition for Verisight Pro 3D ICE Synergizing Hospital, Patient, and Operator Needs\u003c\/p\u003e\n\u003cp\u003e54 Getting off the Struggle Bus Verisight Pro 3D ICE for Tricuspid Transcatheter Edge-to-Edge Repair\u003c\/p\u003e\n\u003cp\u003e55 Verisight Pro 3D ICE Guided LAAO Under Conscious Sedation The Present and Future for Stroke Prevention in AF Patients\u003c\/p\u003e\n\u003cp\u003e56 Stop Spinning to Nowhere Using Verisight Pro 3D ICE for Evoque TTVR\u003c\/p\u003e\n\u003cp\u003e57 LIVE CASE FROM SCRIPPS CLINIC\u003c\/p\u003e\n\u003cp\u003e58 Clinical-Pathological Correlations The Aortic Valve\u003c\/p\u003e\n\u003cp\u003e59 TAVR in 2026 Where Are We and Where Are We Going\u003c\/p\u003e\n\u003cp\u003e60 Procedural Planning for Lifetime TAVI Management and Lessons from Past Mistakes\u003c\/p\u003e\n\u003cp\u003e61 Leaflet Modification to Prevent Coronary Obstruction After TAVR Patient Selection and Technical Approach VIDEO PDF NOT RELEASE\u003c\/p\u003e\n\u003cp\u003e62 Contemporary TAVR for Bicuspid Aortic Valves\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405751111876,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Scripps-15th-Annual-Structural-Heart-Intervention-and-Imaging-2026.jpg?v=1784215648","url":"https:\/\/medicalcoursespro.com\/products\/scripps-15th-annual-structural-heart-intervention-and-imaging-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}